Innovate, Involve, Inspire
ConditionHCV
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorFrontline AIDS
About this trial
The study will test a Community-based Simplified HCV Testing and Treatment Algorithm (CBSA), implemented at community harm reduction fixed or mobile sites.
All potential participants with positive anti-HCV test will undergo diagnostic procedures including HCV-RNA testing. Those eligible for CBSA will be prescribed a fixed dose combination tablet: sofosbuvir/daclatasvir.
Sustained virologic response (SVR) will be assessed 12 weeks after treatment completion. All those who achieve SVR will be tested for HCV\_RNA at six and 12 months after SVR12.
Eligibility criteria
Qualifiers
Drug use in the past 90 days
Age 18 and above
Positive for HCV RNA
Disqualifiers
No meeting inclusion criteria
Pregnancy
Trial design
Treatments tested in this trial
- Community-based Simplified HCV Testing and Treatment Algorithm
Treatment groups
1,454 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Frontline AIDS
Lead sponsor
Alliance for the Public's Health
Collaborator
Source ClinicalTrials.gov